Anti-Biglycan antibody [EPR2959] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal Biglycan antibody. Carrier free. Suitable for WB, Flow Cyt (Intra) and reacts with Mouse, Human, Rat samples. Cited in 1 publication.
View Alternative Names
SLRR1A, BGN, Biglycan, Bone/cartilage proteoglycan I, PG-S1
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Biglycan antibody [EPR2959] - BSA and Azide free (AB205891)
This data was developed using ab109369, the same antibody clone in a different buffer formulation.
Intracellular flow cytometric analysis of permeabilized L6 cells using ab109369 at 1/100 dilution (red) or a rabbit IgG (negative) (green).
- WB
Unknown
Western blot - Anti-Biglycan antibody [EPR2959] - BSA and Azide free (AB205891)
This data was developed using ab109369, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-Biglycan antibody [EPR2959] (<a href='/en-us/products/primary-antibodies/biglycan-antibody-epr2959-ab109369'>ab109369</a>) at 1/1000 dilution
Lane 1:
Rat cartilage lysate at 10 µg
Lane 2:
L6 lysate at 10 µg
Lane 3:
C2C12 lysate at 10 µg
Lane 4:
Human skeletal muscle lysate at 10 µg
Lane 5:
Mouse muscle lysate at 10 µg
Secondary
All lanes:
HRP labelled Goat anti-Rabbit at 1/2000 dilution
Predicted band size: 42 kDa
false
Related conjugates and formulations (1)
-
Anti-Biglycan antibody [EPR2959]
Reactivity data
Product details
ab205891 is the carrier-free version of ab109369.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The protein Biglycan influences cellular processes such as growth and differentiation. It is part of a complex network within the ECM that modulates cell signaling. Biglycan interacts with growth factors like transforming growth factor-beta (TGF-beta) and binds to Toll-like receptors (TLRs) affecting immune responses. These capabilities reveal Biglycan’s involvement in tissue development and repair.
Pathways
Extracellular matrix modulation shows a significant role for Biglycan. It is involved in the TGF-beta signaling pathway and the inflammatory pathway mediated by TLRs. Through these pathways Biglycan interacts with proteins such as decorin and fibromodulin contributing to the regulation of collagen fibrillogenesis and inflammatory responses. Its role in these pathways highlights Biglycan’s influence in cellular communication and matrix regulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 15:4343 PubMed38773197
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com